Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Waters

Showing results (51-60 of 54) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 54 results.
Clinical and Experimental Immunology|June 20, 2023
Efficacy and safety of MAS825 (anti-IL-1β/IL-18) in COVID-19 patients with pneumonia and impaired respiratory functionAlex D Hakim, Mustafa Awili, Hollis R O'Neal, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 20, 2024
Viral and Host Factors Are Associated With Mortality in Hospitalized Patients With COVID-19Neil R Aggarwal, Jacquie Nordwall, Dominique L Braun, et al.
Eclinicalmedicine|April 27, 2022
Tocilizumab in patients hospitalised with COVID-19 pneumonia: Efficacy, safety, viral clearance, and antibody response from a randomised controlled trial (COVACTA)Ivan O Rosas, Norbert Bräu, Michael Waters, et al.
Annals of Internal Medicine|August 8, 2022
Efficacy and Safety of Ensovibep for Adults Hospitalized With COVID-19 : A Randomized Controlled Trial, Christina Barkauskas, Eleftherios Mylonakis, et al.
Pageof 6

Showing results (51-60 of 54) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 54 results.
Clinical and Experimental Immunology|June 20, 2023
Efficacy and safety of MAS825 (anti-IL-1β/IL-18) in COVID-19 patients with pneumonia and impaired respiratory functionAlex D Hakim, Mustafa Awili, Hollis R O'Neal, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 20, 2024
Viral and Host Factors Are Associated With Mortality in Hospitalized Patients With COVID-19Neil R Aggarwal, Jacquie Nordwall, Dominique L Braun, et al.
Eclinicalmedicine|April 27, 2022
Tocilizumab in patients hospitalised with COVID-19 pneumonia: Efficacy, safety, viral clearance, and antibody response from a randomised controlled trial (COVACTA)Ivan O Rosas, Norbert Bräu, Michael Waters, et al.
Annals of Internal Medicine|August 8, 2022
Efficacy and Safety of Ensovibep for Adults Hospitalized With COVID-19 : A Randomized Controlled Trial, Christina Barkauskas, Eleftherios Mylonakis, et al.
Pageof 6